Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

63.02
+1.151.86%
Volume:1.57M
Turnover:98.75M
Market Cap:7.76B
PE:18.37
High:63.14
Open:61.70
Low:61.54
Close:61.87
Loading ...
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 16, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Jan 14, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Nov 18, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.03, 3.02, 8.01, and 9.01
Nov 14, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 12, 2019

Major Issues Report

[Amend] Current report, items 2.05 and 2.06
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 05, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 05, 2019

Major Issues Report

Current report, items 2.05, 2.06, and 5.02
Oct 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Sep 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities